
Catherine R. Oliver-garcia
Examiner (ID: 9259, Phone: (571)272-2655 , Office: P/2914 )
| Most Active Art Unit | 2914 |
| Art Unit(s) | 2904, 2900, 2914 |
| Total Applications | 7479 |
| Issued Applications | 7429 |
| Pending Applications | 0 |
| Abandoned Applications | 54 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 6275735
[patent_doc_number] => 20020106634
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'Method for diagnosing a vascular condition'
[patent_app_type] => new
[patent_app_number] => 10/059920
[patent_app_country] => US
[patent_app_date] => 2002-01-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 19588
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0106/20020106634.pdf
[firstpage_image] =>[orig_patent_app_number] => 10059920
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/059920 | Method for diagnosing a vascular condition | Jan 28, 2002 | Abandoned |
Array
(
[id] => 5935421
[patent_doc_number] => 20020061300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-05-23
[patent_title] => 'Method and composition for treating prostate cancer'
[patent_app_type] => new
[patent_app_number] => 10/055063
[patent_app_country] => US
[patent_app_date] => 2002-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9367
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0061/20020061300.pdf
[firstpage_image] =>[orig_patent_app_number] => 10055063
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/055063 | Method and composition for treating prostate cancer | Jan 21, 2002 | Issued |
Array
(
[id] => 6527829
[patent_doc_number] => 20020192752
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-12-19
[patent_title] => 'Compositions and methods for the treatment of immune related diseases'
[patent_app_type] => new
[patent_app_number] => 10/053107
[patent_app_country] => US
[patent_app_date] => 2002-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 45172
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 16
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0192/20020192752.pdf
[firstpage_image] =>[orig_patent_app_number] => 10053107
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/053107 | Compositions and methods for the treatment of immune related diseases | Jan 16, 2002 | Abandoned |
Array
(
[id] => 6750947
[patent_doc_number] => 20030045468
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Compositions and methods for the therapy, diagnosis and monitoring of breast cancer'
[patent_app_type] => new
[patent_app_number] => 10/042945
[patent_app_country] => US
[patent_app_date] => 2002-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 24291
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045468.pdf
[firstpage_image] =>[orig_patent_app_number] => 10042945
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/042945 | Compositions and methods for the therapy, diagnosis and monitoring of breast cancer | Jan 7, 2002 | Abandoned |
Array
(
[id] => 6740207
[patent_doc_number] => 20030157576
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-21
[patent_title] => 'Epithelial cell growth inhibitors'
[patent_app_type] => new
[patent_app_number] => 10/028952
[patent_app_country] => US
[patent_app_date] => 2001-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 6106
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0157/20030157576.pdf
[firstpage_image] =>[orig_patent_app_number] => 10028952
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/028952 | Epithelial cell growth inhibitors | Dec 17, 2001 | Issued |
Array
(
[id] => 6178599
[patent_doc_number] => 20020156247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-24
[patent_title] => 'Mammalian checkpoint genes and proteins'
[patent_app_type] => new
[patent_app_number] => 10/020038
[patent_app_country] => US
[patent_app_date] => 2001-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18945
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0156/20020156247.pdf
[firstpage_image] =>[orig_patent_app_number] => 10020038
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/020038 | Mammalian checkpoint genes and proteins | Dec 11, 2001 | Abandoned |
Array
(
[id] => 6865141
[patent_doc_number] => 20030190667
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-10-09
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 10/015480
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 250
[patent_figures_cnt] => 250
[patent_no_of_words] => 283276
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0190/20030190667.pdf
[firstpage_image] =>[orig_patent_app_number] => 10015480
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/015480 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 10, 2001 | Issued |
Array
(
[id] => 6156697
[patent_doc_number] => 20020146396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells'
[patent_app_type] => new
[patent_app_number] => 10/014877
[patent_app_country] => US
[patent_app_date] => 2001-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 29125
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146396.pdf
[firstpage_image] =>[orig_patent_app_number] => 10014877
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/014877 | Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells | Dec 10, 2001 | Issued |
Array
(
[id] => 6628567
[patent_doc_number] => 20020086408
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-07-04
[patent_title] => 'Ubiquitin-like conjugating protein'
[patent_app_type] => new
[patent_app_number] => 10/013742
[patent_app_country] => US
[patent_app_date] => 2001-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19846
[patent_no_of_claims] => 57
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20020086408.pdf
[firstpage_image] =>[orig_patent_app_number] => 10013742
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/013742 | Ubiquitin-like conjugating protein | Dec 6, 2001 | Abandoned |
Array
(
[id] => 6706192
[patent_doc_number] => 20030152926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-08-14
[patent_title] => 'Novel methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators'
[patent_app_type] => new
[patent_app_number] => 10/021660
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 69752
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0152/20030152926.pdf
[firstpage_image] =>[orig_patent_app_number] => 10021660
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/021660 | Novel methods of diagnosis of angiogenesis, compositions and methods of screening for angiogenesis modulators | Dec 5, 2001 | Abandoned |
Array
(
[id] => 1022032
[patent_doc_number] => 06887975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-05-03
[patent_title] => 'Peptides derived from STEAP1'
[patent_app_type] => utility
[patent_app_number] => 10/010667
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 28
[patent_no_of_words] => 20757
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/887/06887975.pdf
[firstpage_image] =>[orig_patent_app_number] => 10010667
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/010667 | Peptides derived from STEAP1 | Dec 5, 2001 | Issued |
Array
(
[id] => 6110919
[patent_doc_number] => 20020172935
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-11-21
[patent_title] => 'Methods of screening for compounds that modulate blood vessel formation from circulating endothelial cell precursors'
[patent_app_type] => new
[patent_app_number] => 10/010762
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 14771
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0172/20020172935.pdf
[firstpage_image] =>[orig_patent_app_number] => 10010762
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/010762 | Methods of screening for compounds that modulate blood vessel formation from circulating endothelial cell precursors | Dec 5, 2001 | Abandoned |
Array
(
[id] => 695767
[patent_doc_number] => 07071304
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-07-04
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => utility
[patent_app_number] => 10/006117
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 249
[patent_figures_cnt] => 249
[patent_no_of_words] => 279663
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/071/07071304.pdf
[firstpage_image] =>[orig_patent_app_number] => 10006117
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/006117 | Secreted and transmembrane polypeptides and nucleic acids encoding the same | Dec 5, 2001 | Issued |
Array
(
[id] => 6751161
[patent_doc_number] => 20030045682
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'Antibodies immunospecific for STEAP1'
[patent_app_type] => new
[patent_app_number] => 10/011095
[patent_app_country] => US
[patent_app_date] => 2001-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 21019
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0045/20030045682.pdf
[firstpage_image] =>[orig_patent_app_number] => 10011095
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/011095 | Antibodies immunospecific for STEAP1 | Dec 5, 2001 | Issued |
Array
(
[id] => 6860548
[patent_doc_number] => 20030091556
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-15
[patent_title] => 'Methods of inhibiting tumor growth and angiogenesis with anastellin'
[patent_app_type] => new
[patent_app_number] => 10/005171
[patent_app_country] => US
[patent_app_date] => 2001-12-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 10388
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20030091556.pdf
[firstpage_image] =>[orig_patent_app_number] => 10005171
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/005171 | Methods of inhibiting tumor growth and angiogenesis with anastellin | Dec 2, 2001 | Abandoned |
Array
(
[id] => 6157832
[patent_doc_number] => 20020146804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-10-10
[patent_title] => 'Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use'
[patent_app_type] => new
[patent_app_number] => 09/989903
[patent_app_country] => US
[patent_app_date] => 2001-11-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 17367
[patent_no_of_claims] => 55
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0146/20020146804.pdf
[firstpage_image] =>[orig_patent_app_number] => 09989903
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/989903 | Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use | Nov 19, 2001 | Issued |
Array
(
[id] => 6378070
[patent_doc_number] => 20020119531
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-29
[patent_title] => 'Prostate-associated protease antibody'
[patent_app_type] => new
[patent_app_number] => 09/988975
[patent_app_country] => US
[patent_app_date] => 2001-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 14564
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0119/20020119531.pdf
[firstpage_image] =>[orig_patent_app_number] => 09988975
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/988975 | Prostate-associated protease antibody | Nov 18, 2001 | Abandoned |
Array
(
[id] => 6813540
[patent_doc_number] => 20030073090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-04-17
[patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same'
[patent_app_type] => new
[patent_app_number] => 09/990439
[patent_app_country] => US
[patent_app_date] => 2001-11-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 331
[patent_figures_cnt] => 331
[patent_no_of_words] => 289205
[patent_no_of_claims] => 118
[patent_no_of_ind_claims] => 42
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0073/20030073090.pdf
[firstpage_image] =>[orig_patent_app_number] => 09990439
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/990439 | Nucleic acids encoding PRO830 | Nov 15, 2001 | Issued |
Array
(
[id] => 946689
[patent_doc_number] => 06965023
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2005-11-15
[patent_title] => 'Death domain proteins'
[patent_app_type] => utility
[patent_app_number] => 10/001254
[patent_app_country] => US
[patent_app_date] => 2001-11-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 33
[patent_no_of_words] => 33033
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/965/06965023.pdf
[firstpage_image] =>[orig_patent_app_number] => 10001254
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/001254 | Death domain proteins | Nov 14, 2001 | Issued |
| 09/913557 | Peptides | Nov 6, 2001 | Abandoned |